<![CDATA[Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer]]>

Summary

Allegheny Health Network Department of Urology is offering a gemcitabine intravesical system to treat BCG-unresponsive non-muscle invasive bladder cancer. This is a routine clinical practice announcement without trial data, regulatory decisions, or financial implications.